AXS Investments’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,000
Closed -$143K 404
2023
Q4
$143K Buy
+10,000
New +$142K 0.03% 314
2023
Q3
Sell
-21,383
Closed -$252K 463
2023
Q2
$252K Sell
21,383
-26,419
-55% -$301K 0.07% 251
2023
Q1
$550K Buy
47,802
+20,493
+75% +$254K 0.18% 174
2022
Q4
$339K Buy
+27,309
New +$348K 0.12% 179
2022
Q3
Sell
-69,848
Closed -$976K 218
2022
Q2
$976K Buy
+69,848
New +$934K 0.35% 100

Other funds holding SBRA

AXS Investments's SBRA Position: Q1 2024 in Review

AXS Investments sold out of Sabra Healthcare REIT (SBRA) in Q1 2024, closing a stake of 10,000 shares — an estimated $143K sold.

AXS Investments first reported a position in SBRA in Q2 2022 and held it in 5 quarters. The position peaked at $976K in Q2 2022. 342 funds tracked by Wall St. Rank hold SBRA as of Q1 2024.

  • AXS Investments reported no remaining Sabra Healthcare REIT position as of Q1 2024 after selling out during the quarter.
  • AXS Investments sold 10,000 Sabra Healthcare REIT shares in Q1 2024, an estimated $143K.
  • AXS Investments first reported a position in Sabra Healthcare REIT in Q2 2022 and held it in 5 quarters.
  • AXS Investments's Sabra Healthcare REIT position peaked at $976K in Q2 2022.
  • 342 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2024.

Based on AXS Investments's 13F filing for Q1 2024, filed 13 May 2024.